6Nishihara C, Kuratsukuri K, Tanaka T, et al. Successful combined treat- ment with maximal androgen blockade (MAB), intra arterial chemo- therapy and radiation for advanced prostatic ductal adenocarcinoma:re- port of two cases[ J]. Hinyokika Kiyo,2011,57(4) :209-212. 被引量：1
4Kyrianou N. Apoptosis therapeutic significance in the treatment of androgen dependent and androgen- independent prostate cancer. World J Urol, 1994, 12: 299. 被引量：1
5Vogelzang N J, Chodak GW, Soloway MS, et al. Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. J Urol, 1995, 46: 220-226. 被引量：1
6Labrie F,Candas B, Gomez JL, et al. Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer? Urology, 2002, 60: 115-119. 被引量：1
7Klotz L, Schellhammer P, Carroll K. A re-assessment of the role of combined androgen blockade for advanced prostate cancer. BJU Int, 2004, 93: 1177-1182. 被引量：1
8Olson KB, Pienta KJ. Pain management in patients with advanced prostate cancer. Oncology, 1999, 13.. 1537-1549. 被引量：1
9SUZUKI H, KAMIYA N, IMAMOTO T, et al. Current topics and perspectives relating to hormone therapy for prostate cancer [ J ] . Int J Clin Oncol, 2008, 13(5): 401-410. 被引量：1
10HAAS G P, DELONGCHAMPS N, BRAWLEY O W, et al. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies [ J ]. Can J Urol, 2008, 15(1): 3866- 3871. 被引量：1
